Intuitive Investments Group provides investors with exposure to a portfolio concentrating on fast growing and high potential life sciences businesses. The firm operates predominantly in the UK, continental Europe and the US.
Portfolio
2
companies
Optellum
Optellum develops artificial intelligence software to diagnose early-stage lung cancer.
PneumoWave
PneumoWave develops a wearable biosensor platform for remote respiratory monitoring.
Robert Naylor
CEO
The Scottish National Investment Bank led the Series A round to accelerate clinical validation and regulatory submission of the company's respiratory monitoring platform.
"We are delighted to close this round and thank both our existing investors and the Scottish National Investment Bank for their support,"
The Oxford medical technology company secured backing from investors including Mercia and IQ Capital to scale its diagnostic software.
"Following years of research and clinical trials that have shown the impact of our software on the diagnosis of at-risk lung nodules, we’re focused on expanding patient access to this crucial technology and identifying deadly lung cancer faster in more at-risk people. The funding will also boost our research and development with world-leading institutions and partners to progress further innovation."
